TSLP dysregulates Th2 immune responses, increasing the production of inflammatory cytokines like IL-4, IL-5, IL-13, and IL-31 by activating the dendritic cells, thus initiating the inflammatory responses in AD. Here, IL31 is linked to Alzheimer disease.